Elon Musk faces criticism over right-wing causes and cuts to the U.S. federal workforce, affecting Tesla's sales and stock.

Company boards must understand the role of director qualifications in satisfying the duty of oversight and the expectations of regulators and institutional investors. To withstand stakeholder scrutiny ...

Elon Musk’s EV company is struggling as he plunges into politics. Robyn Denholm, the Australian chair of Tesla, is thriving ...

MIRA Pharmaceuticals (MIRA) announced the approval and upcoming initiation of its Phase 1 clinical trial for Ketamir-2, the Company’s novel ...

MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...

A fresh controversy has emerged within Cricket Scotland as new findings suggest that former cricketer Majid Haq faced ...

The two-year test may bring the Navy — and perhaps the other services — closer to scientific consensus on the best way to ...

Worrying times for IndusInd Bank. Brokerages downgrade stock on concerns that about a negative derivatives’ disclosure and ...

Years of studying Satoshi Nakamoto led me to a new prime suspect. What if crypto’s creator isn’t the benign figure people ...